GMP facility current to concept

Vernal Biosciences Featured in Endpoints News

After a successful extension of its Series A funding, Vernal Biosciences was featured in an Endpoints News article by Tyler Patchen. Find out how we are using these funds to widen our offerings and support the mRNA community, then click…

Gray Typographic Media Newsletter

April Newsletter

We cannot believe it has been 2 years. Happy Birthday Vernal Biosciences! See how Vernal has grown since 2021 and expanded its capabilities for mRNA, LNP, and GMP!

Vernal’s World Vaccine Congress Poster

Anti-SARS-CoV-2 Spike Protein Responses

Poster Abstract: Based on the clinical and commercial success of SARS-CoV-2 mRNA vaccines, interest in using lipid nanoparticle-formulated mRNA (LNP-mRNA) as a next generation, rapidly deployable vaccine platform has accelerated in the form of preclinical research and clinical trials. To…

mRNA Vaccine Timeline

Potent Immune Response with Vernal’s LNP-mRNAs

The development of mRNA vaccines has been ongoing since the late 80s, but it wasn’t until the COVID-19 pandemic that this technology became widely recognized.  Instead of using an antigen to trigger the body’s immune system to create a new…

Gray Typographic Media Newsletter

Vernal’s First Newsletter!

Vernal’s mission has always been to democratize access to mRNA. One of the ways we are achieving this is expanding our capabilities in mRNA process and development so that we can provide GMP for clinical use cases. Take a look…

6 lab technicians

Vernal’s Growth Since 2021

Seven Days wrote a great follow up article on Vernal’s growth since the summer of 2021. Click the link below to see what we’ve been up to. What a difference a year makes! New Companies Are Riding Vermont’s Health Tech…

Construction being done on the new Manufacturing Facility for Vernal Biosciences

Vernal Starts Construction on Vermont mRNA Facility

Vernal Biosciences is excited to announce the start of construction on its new, 23,000 square foot mRNA manufacturing facility in Essex Junction, Vt. The new facility will include state-of-the-art equipment and clean rooms to support clinical mRNA and LNP mRNA…